A Label-Free Immunosensor for CEA Based on Pd-Ir Bimetallic Nanoparticles.

Area of Science:

• Electrochemistry
• Nanotechnology
• Biomedical Engineering

Background:

• Carcinoembryonic antigen (CEA) is a significant biomarker for various cancers.
• Accurate and rapid detection of CEA is crucial for early diagnosis and monitoring.
• Existing detection methods often require complex procedures or labels.

Purpose of the Study:

• To develop a novel label-free immunosensor for the rapid detection of CEA.
• To utilize Pd-Ir bimetallic nanoparticles as a catalyst for enhanced sensitivity.
• To establish a simple and effective method for CEA determination.

Main Methods:

• Immobilization of CEA antibody (anti-CEA) onto a glassy carbon electrode modified with Pd-Ir bimetallic nanoparticles and chitosan.
• Utilizing the blocking effect of immunocomplex formation on the catalytic activity of Pd-Ir nanoparticles towards H2O2 reduction.
• Electrochemical detection based on the decrease in current response.

Main Results:

• The immunosensor demonstrated a linear response to CEA concentration in the range of 0.05 ng/mL to 50 ng/mL.
• A low detection limit of 0.017 ng/mL (at 3σ) was achieved.
• The sensor operates in a label-free manner, simplifying the detection process.

Conclusions:

• The developed Pd-Ir bimetallic nanoparticle-based immunosensor provides a simple and sensitive platform for CEA detection.
• This method offers a promising new approach for the rapid determination of carcinoembryonic antigen.
• The label-free nature and high sensitivity make it suitable for clinical applications.